This Fiscal Note is not an official copy and should not be quoted or cited.
Fiscal Note - SB 0782 - Revises definition of maintenance drugs
SB 782 - Fiscal Note

COMMITTEE ON LEGISLATIVE RESEARCH

OVERSIGHT DIVISION

FISCAL NOTE

L.R. NO. 2429-01

BILL NO. SB 782

SUBJECT: Health Care; Health Care Professionals; Insurance - Medical

TYPE: Original

DATE: January 30, 1998


FISCAL SUMMARY

ESTIMATED NET EFFECT ON STATE FUNDS

FUND AFFECTED FY 1999 FY 2000 FY 2001
None
Total Estimated

Net Effect on All

State Funds

$0 $0 $0



ESTIMATED NET EFFECT ON FEDERAL FUNDS

FUND AFFECTED FY 1999 FY 2000 FY 2001
None
Total Estimated

Net Effect on All

Federal Funds

$0 $0 $0



ESTIMATED NET EFFECT ON LOCAL FUNDS

FUND AFFECTED FY 1999 FY 2000 FY 2001
Local Government $0 $0 $0

Numbers within parentheses: ( ) indicate costs or losses

This fiscal note contains 3 pages.



FISCAL ANALYSIS

ASSUMPTION

Officials from the Office of Administration, the Department of Insurance, the Department of Transportation, the Department of Conservation, the Department of Public Safety - Missouri State Highway Patrol, the Missouri Consolidated Health Care Plan, the Department of Corrections, and the Department of Social Services assume this proposal would not fiscally impact their agencies.

FISCAL IMPACT - State Government FY 1999 FY 2000 FY 2001
(10 Mo.)
$0 $0 $0
FISCAL IMPACT - Local Government FY 1999 FY 2000 FY 2001
(10 Mo.)
$0 $0 $0
FISCAL IMPACT - Small Business

No direct fiscal impact to small businesses would be expected as a result of this proposal.

DESCRIPTION

This proposal would amend one section contained in HB 335 (1997), relating to the definition of maintenance drugs covered under a health maintenance organization (HMO). Under current law, both the enrollee and the enrollee's physician must approve the substitution of a generic drug for a prescribed maintenance drug. The law excludes "narrow therapeutic index drugs" from the definition of maintenance drugs to allow generic substitution for these drugs without physician/enrollee approval. This proposal would remove language that indirectly allows generic

substitution for narrow therapeutic index drugs, with the result that physician/enrollee approval would be required prior to a generic substitution for these drugs.

This legislation is not federally mandated, would not duplicate any other program and would not require additional capital improvements or rental space.

SOURCES OF INFORMATION

Department of Insurance

Missouri Consolidated Health Care Plan

SOURCES OF INFORMATION (continued)

Department of Social Services

Department of Conservation

Office of Administration

Department of Transportation

Department of Public Safety

Missouri State Highway Patrol

Department of Corrections







Jeanne Jarrett, CPA

Director

January 30, 1998